Edward G. Bridges

1.2k citations

25 papers · 918 indexed · h-index 16

Co-authors: Jean‐Pierre Sommadossi Yung‐Chi Cheng Claire Pierra Gilles Gosselin Andrea M Nazar Kristie Grove Bridges Ginger E. Dutschman Erika Cretton-Scott
Topics: HIV/AIDS drug development and treatment (11 papers)Hepatitis C virus research (9 papers)Hepatitis B Virus Studies (8 papers)
Cited by: Hepatology Virology Infectious Diseases
Journals: Journal of Biological Chemistry The FASEB Journal Journal of Medicinal Chemistry
Partner nations: United States France Italy

In The Last Decade

Edward G. Bridges

25 papers receiving 871 citations

Peers

Countries citing papers authored by Edward G. Bridges

Since Specialization

Citations

This map shows the geographic impact of Edward G. Bridges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward G. Bridges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward G. Bridges more than expected).

Fields of papers citing papers by Edward G. Bridges

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward G. Bridges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward G. Bridges. The network helps show where Edward G. Bridges may publish in the future.

Co-authorship network of co-authors of Edward G. Bridges

This figure shows the co-authorship network connecting the top 25 collaborators of Edward G. Bridges. A scholar is included among the top collaborators of Edward G. Bridges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward G. Bridges. Edward G. Bridges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer 2023 ·Journal of Experimental & Clinical Cancer Research ·Ellen C. de Heer,Christos E. Zois,Edward G. Bridges,Bert van der Vegt,Helen Sheldon,(unknown),Mieke C. Zwager,Tineke van der Sluis,Syed Haider,Tatsuo Morita,Otto Baba,C.P. Schröder,Steven de Jong,Adrian L. Harris,Mathilde Jalving	9
2	Salivary uric acid as a noninvasive biomarker of metabolic syndrome 2012 ·Diabetology & Metabolic Syndrome ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Edward G. Bridges,Andrea M Nazar,Kristie Grove Bridges	108
3	Detection of Homocysteine and C-Reactive Protein in the Saliva of Healthy Adults: Comparison with Blood Levels 2010 ·Biomarker Insights ·(unknown),(unknown),(unknown),(unknown),(unknown),Edward G. Bridges,Andrea M Nazar,Kristie Grove Bridges	68
4	Nonclinical Safety Profile of Telbivudine, a Novel Potent Antiviral Agent for Treatment of Hepatitis B 2008 ·Antimicrobial Agents and Chemotherapy ·Edward G. Bridges,J.R. Selden,Shouqi Luo	23
5	Synthesis and Pharmacokinetics of Valopicitabine (NM283), an Efficient Prodrug of the Potent Anti-HCV Agent 2‘-C-Methylcytidine 2006 ·Journal of Medicinal Chemistry ·Claire Pierra,Agnès Amador,S. Benzaria,Erika Cretton-Scott,(unknown),John Mao,Steven R. Mathieu,Adel Moussa,Edward G. Bridges,David N. Standring,Jean‐Pierre Sommadossi,Richard Storer,Gilles Gosselin	147
6	Synthesis, Physicochemical and Pharmacokinetic Studies of Potential Prodrugs of β-L-2′-Deoxycytidine, a Selective and Specific Anti-HBV Agent 2004 ·Antiviral chemistry & chemotherapy ·Claire Pierra,S. Benzaria,David Dukhan,Anna Giulia Loi,Paolo La Colla,Edward G. Bridges,John Mao,David N. Standring,Jean‐Pierre Sommadossi,Gilles Gosselin	3
7	Monoval-LdC: Efficient Prodrug of 2′-Deoxy-β-L-cytidine (L-dC), A Potent and Selective Anti-HBV Agent 2003 ·Nucleosides Nucleotides & Nucleic Acids ·S. Benzaria,Claire Pierra,Dorothée Bardiot,(unknown),Edward G. Bridges,Xiaojian Zhou,David N. Standring,Gilles Gosselin	3
8	NM 283 has potent antiviral activity against genotype 1 chronic hepatitis C virus (HCV-1) infection in the chimpanzee 2003 ·Journal of Hepatology ·David N. Standring,Robert E. Lanford,Teresa L. Wright,Ray Chung,V. Bichko,(unknown),(unknown),Svetlana Bergelson,(unknown),(unknown),Edward G. Bridges,(unknown),Richard Storer,Claire Pierra,S. Benzaria,(unknown),P. La Colla,Jean‐Pierre Sommadossi	15
9	Pharmacology of β- l -Thymidine and β- l -2′-Deoxycytidine in HepG2 Cells and Primary Human Hepatocytes: Relevance to Chemotherapeutic Efficacy against Hepatitis B Virus 2002 ·Antimicrobial Agents and Chemotherapy ·Brenda I. Hernández-Santiago,L Placidi,(unknown),Achraf Al Faraj,Edward G. Bridges,Martin L. Bryant,José F. Rodríguez‐Orengo,Jean‐Louis Imbach,Gilles Gosselin,Claire Pierra,David Dukhan,Jean‐Pierre Sommadossi	43
10	ANTI-HBV SPECIFIC β-L-2′-DEOXYNUCLEOSIDES 2001 ·Nucleosides Nucleotides & Nucleic Acids ·Martin L. Bryant,Edward G. Bridges,L Placidi,Abdesslem Faraj,(unknown),Claire Pierra,David Dukhan,Gilles Gosselin,Jean‐Louis Imbach,Brenda Y. Hernandez,(unknown),Bud C. Tennant,Brent Korba,Paul J. Côté,Erika Cretton-Scott,Raymond F. Schinazi,Jean‐Pierre Sommadossi	23
11	Antiviral l -Nucleosides Specific for Hepatitis B Virus Infection 2001 ·Antimicrobial Agents and Chemotherapy ·Martin L. Bryant,Edward G. Bridges,L Placidi,Abdesslem Faraj,(unknown),Claire Pierra,David Dukhan,Gilles Gosselin,Jean‐Louis Imbach,Brenda Y. Hernandez,(unknown),Bud C. Tennant,Brent E. Korba,Paul J. Côté,(unknown),Erika Cretton-Scott,Raymond F. Schinazi,Jean‐Pierre Sommadossi	144
12	Characterization of a dCTP Transport Activity Reconstituted from Human Mitochondria 1999 ·Journal of Biological Chemistry ·Edward G. Bridges,Zaoli Jiang,Yung‐Chi Cheng	61
13	Metabolism of 2′,3′-Dideoxy-2′,3′-Didehydro-β- l (−)-5-Fluorocytidine and Its Activity in Combination with Clinically Approved Anti-Human Immunodeficiency Virus β- d (+) Nucleoside Analogs In Vitro 1998 ·Antimicrobial Agents and Chemotherapy ·Ginger E. Dutschman,Edward G. Bridges,Shwu-Huey Liu,Elizabeth A. Gullen,(unknown),Marina K. Kukhanova,Yung‐Chi Cheng	40
14	Favorable interaction of β-l(−) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus 1996 ·Biochemical Pharmacology ·Edward G. Bridges,Ginger E. Dutschman,Elizabeth A. Gullen,Yung‐Chi Cheng	29
15	3‘‐Azido‐ 3’‐deoxythymidine inhibits erythroid‐specific transcription factors in human erythroid K562 leukemia cells 1996 ·European Journal Of Haematology ·Edward G. Bridges,(unknown),Rachid Lahlil,(unknown),Pierre Jeannesson,Jean‐Pierre Sommadossi	7
16	Use of novel beta-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma. 1995 ·PubMed ·Edward G. Bridges,Yang Cheng	15
17	Inhibition of mammalian dna polymerase-associated 3′ to 5′ exonuclease activity by 5′-monophosphates of 3′-azido-3′-deoxythymidine and 3′-amino-3′-deoxythymidine 1993 ·Biochemical Pharmacology ·Edward G. Bridges,Abdesslem Faraj,Jean‐Pierre Sommadossi	32
18	Influence of template primary structure on 3′-azido-3′-deoxythymidine triphosphate incorporation into DNA 1993 ·Antiviral Research ·Edward G. Bridges,(unknown),Douglas A. Weidner,Jean‐Pierre Sommadossi	4
19	Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cells. 1992 ·Molecular Pharmacology ·Douglas A. Weidner,Edward G. Bridges,E M Cretton,Jean‐Pierre Sommadossi	23
20	THE REFORMS OF 1854 IN RETROSPECT 1954 ·The Political Quarterly ·Edward G. Bridges	3

About Edward G. Bridges

Edward G. Bridges is a scholar working on Hepatology, Infectious Diseases and Family Practice, having authored 25 papers that have together received 918 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (11 papers), Hepatitis C virus research (9 papers) and Hepatitis B Virus Studies (8 papers). The work is most often cited by research in Hepatology (315 citations), Virology (147 citations) and Infectious Diseases (413 citations). Edward G. Bridges has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Jean‐Pierre Sommadossi, Yung‐Chi Cheng, Claire Pierra, Gilles Gosselin, Andrea M Nazar, Kristie Grove Bridges, Ginger E. Dutschman, Erika Cretton-Scott, Abdesslem Faraj and Zaoli Jiang. Their work appears in journals such as Journal of Biological Chemistry, The FASEB Journal and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact